Stefan Unterecker

3.4k total citations
71 papers, 818 citations indexed

About

Stefan Unterecker is a scholar working on Psychiatry and Mental health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stefan Unterecker has authored 71 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 24 papers in Pharmacology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stefan Unterecker's work include Treatment of Major Depression (21 papers), Bipolar Disorder and Treatment (17 papers) and Schizophrenia research and treatment (15 papers). Stefan Unterecker is often cited by papers focused on Treatment of Major Depression (21 papers), Bipolar Disorder and Treatment (17 papers) and Schizophrenia research and treatment (15 papers). Stefan Unterecker collaborates with scholars based in Germany, United States and Ireland. Stefan Unterecker's co-authors include Jürgen Deckert, Bruno Pfuhlmann, Maike Scherf‐Clavel, Peter Riederer, Christoph Hiemke, Martin J. Herrmann, Christian Jacob, Andreas J. Fallgatter, Gudrun Hefner and Tanja Falter and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Pain.

In The Last Decade

Stefan Unterecker

67 papers receiving 802 citations

Peers

Stefan Unterecker
Judith C. Kando United States
C. Barnas Austria
Jonathan G. Leung United States
I. Gaertner Germany
Kristin L. Bigos United States
Stefan Unterecker
Citations per year, relative to Stefan Unterecker Stefan Unterecker (= 1×) peers Bruno Pfuhlmann

Countries citing papers authored by Stefan Unterecker

Since Specialization
Citations

This map shows the geographic impact of Stefan Unterecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Unterecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Unterecker more than expected).

Fields of papers citing papers by Stefan Unterecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Unterecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Unterecker. The network helps show where Stefan Unterecker may publish in the future.

Co-authorship network of co-authors of Stefan Unterecker

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Unterecker. A scholar is included among the top collaborators of Stefan Unterecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Unterecker. Stefan Unterecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scherf‐Clavel, Maike, et al.. (2025). Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy. British Journal of Clinical Pharmacology. 91(9). 2636–2648.
2.
Scherf‐Clavel, Maike, Heike Weber, Leif Hommers, et al.. (2025). CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations. Journal of Psychopharmacology. 39(8). 847–854. 1 indexed citations
3.
Scherf‐Clavel, Maike, et al.. (2025). Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range. Pharmacopsychiatry. 58(3). 127–131. 1 indexed citations
4.
Unterecker, Stefan, et al.. (2024). Serum Concentration of Antidepressant Drugs in Geriatric Day Care Patients With Renal Insufficiency and Multimorbidity. Therapeutic Drug Monitoring. 47(2). 297–302.
5.
Scherf‐Clavel, Maike, Heike Weber, Stefan Unterecker, Daniel J. Müller, & Jürgen Deckert. (2024). Frequencies of CYP2C19 and CYP2D6 gene variants in a German inpatient sample with mood and anxiety disorders. The World Journal of Biological Psychiatry. 25(4). 214–221.
7.
Huang, Jue, Holger Bogatsch, Thomas Ethofer, et al.. (2024). The impact of emotional dysregulation and comorbid depressive symptoms on clinical features, brain arousal, and treatment response in adults with ADHD. Frontiers in Psychiatry. 14. 1294314–1294314. 5 indexed citations
8.
Scherf‐Clavel, Maike, Andreas Eckert, Heike Weber, et al.. (2023). Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. International Journal of Clinical Pharmacy. 45(5). 1107–1117. 8 indexed citations
9.
Üçeyler, Nurcan, et al.. (2022). Reduced midbrain raphe echogenicity in patients with fibromyalgia syndrome. PLoS ONE. 17(11). e0277316–e0277316. 3 indexed citations
10.
Scherf‐Clavel, Maike, et al.. (2022). Psychotropic medication in pregnancy and lactation and early development of exposed children. British Journal of Clinical Pharmacology. 89(2). 737–750. 10 indexed citations
11.
Hommers, Leif, Maike Scherf‐Clavel, Julian Roth, et al.. (2021). Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age. Journal of Psychopharmacology. 35(9). 1127–1133. 12 indexed citations
12.
Scherf‐Clavel, Maike, Leif Hommers, Jürgen Deckert, et al.. (2020). Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine. Journal of Psychopharmacology. 34(10). 1105–1111. 11 indexed citations
13.
Strauß, Maria, David Petroff, Jue Huang, et al.. (2020). The “VIP-ADHD trial”: Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?. European Neuropsychopharmacology. 43. 116–128. 3 indexed citations
14.
Scherf‐Clavel, Maike, et al.. (2019). Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients. European Journal of Clinical Pharmacology. 76(1). 73–80. 2 indexed citations
15.
Scherf‐Clavel, Maike, et al.. (2019). Determination of hydroxybupropion in human serum for routine therapeutic drug monitoring in psychiatry: A tool for dose‐individualization in treatment with bupropion. Biomedical Chromatography. 33(10). e4609–e4609. 4 indexed citations
16.
Werner, Rudolf A., Ryohei Kobayashi, Mehrbod S. Javadi, et al.. (2018). Impact of Novel Antidepressants on Cardiac123I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits. Journal of Nuclear Medicine. 59(7). 1099–1103. 9 indexed citations
17.
Paulzen, Michael, Ekkehard Haen, Benedikt Stegmann, et al.. (2016). Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns. European Archives of Psychiatry and Clinical Neuroscience. 267(4). 325–333. 19 indexed citations
18.
Hefner, Gudrun, Mohamed E. E. Shams, Stefan Unterecker, Tanja Falter, & Christoph Hiemke. (2015). Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels. Psychopharmacology. 233(9). 1695–1705. 62 indexed citations
19.
Unterecker, Stefan, et al.. (2013). Interaction of Valproic Acid and Amitriptyline. Journal of Clinical Psychopharmacology. 33(4). 561–564. 4 indexed citations
20.
Unterecker, Stefan, Florian Proft, Peter Riederer, et al.. (2013). The Comparison of Brand-Name and Generic Formulations of Venlafaxine. Therapeutic Drug Monitoring. 36(2). 269–272. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026